MaxCyte, Inc. (LON:MXCT – Get Free Report)’s share price crossed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of GBX 1.21 and traded as low as GBX 1.20. MaxCyte shares last traded at GBX 1.25, with a volume of 12,670,056 shares.
MaxCyte Stock Up 4.0%
The firm has a fifty day moving average of GBX 1.21 and a 200-day moving average of GBX 1.10. The company has a quick ratio of 14.38, a current ratio of 10.88 and a debt-to-equity ratio of 8.74. The firm has a market cap of £1.38 million, a P/E ratio of -0.03 and a beta of 1.13.
MaxCyte Company Profile
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.
See Also
- Five stocks we like better than MaxCyte
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.
